Massivemarkets

SEC Form 4

Cellebrite DI Ltd. (CLBT) insider trading

In the 12 months to Oct 26, 2026, 4 CLBT insiders reported open-market sales of $5.4M across 14 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$5.4M
14 filings · 4 insiders
Open-market purchases
$0
0 filings
Pre-arranged sales (10b5-1)
2 of 14
$123.6K of $5.4M sold (2%)

Who traded CLBT, and when

  • Sale
  • Sale, pre-arranged (10b5-1)

CLBT daily close from Oct 27, 2025 to Oct 26, 2026, between $10.44 and $19.28, last $12.17. 14 sale and 0 purchase filings by 4 insiders, marked at their filing dates. Thomas E. Hogan, Chief Executive Officer → Other: sold $4.1M across 3 filings, first filed Jul 7, 2026, last Aug 27, 2026. David Barter, Chief Financial Officer: sold $819.5K across 2 filings, first filed Jul 9, 2026, last Oct 19, 2026. Marcus Jewell, Global Chief Revenue Officer: sold $314.5K across 4 filings, first filed May 14, 2026, last Aug 24, 2026. David Nicholas Gee, Chief Marketing Officer: sold $155.0K across 5 filings, first filed May 14, 2026, last Aug 25, 2026.

Largest mark · tap a row for others

Thomas E. Hogan · Chief Executive Officer

Sale $2,149,638

139,713 shares

Filed Aug 13, 2026 · traded Aug 12

Close on filing date $10.80

CLBT daily closelast $12.17

Thomas E. Hogan · Chief Executive Officer → Other

$4.1M sold

David Barter · Chief Financial Officer

$819.5K sold

Marcus Jewell · Global Chief Revenue Officer

$314.5K sold

David Nicholas Gee · Chief Marketing Officer

$155.0K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

14 filings in the last 12 months
Other insider activity (not market trades) · 10 records
  • Grants and awards10 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Role
The title on each filing. Someone whose title changed shows more than one.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Cellebrite DI Ltd.'s CEO sold stock?

Yes. Thomas E. Hogan (CEO) sold 242,901 shares ($3.8M) between Jul 2026 and Aug 2026. Shiven Ramji (CEO) made no open-market sales filed as CEO in the last 12 months.

How current is CLBT’s insider data?

These are CLBT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track CLBT insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CLBT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.